MXPA02009056A - Proceso para la preparacion de formulaciones de liberacion acelerada usando fluidos comprimidos. - Google Patents

Proceso para la preparacion de formulaciones de liberacion acelerada usando fluidos comprimidos.

Info

Publication number
MXPA02009056A
MXPA02009056A MXPA02009056A MXPA02009056A MXPA02009056A MX PA02009056 A MXPA02009056 A MX PA02009056A MX PA02009056 A MXPA02009056 A MX PA02009056A MX PA02009056 A MXPA02009056 A MX PA02009056A MX PA02009056 A MXPA02009056 A MX PA02009056A
Authority
MX
Mexico
Prior art keywords
active ingredient
compressed fluid
accelerated release
preparation
release formulations
Prior art date
Application number
MXPA02009056A
Other languages
English (en)
Inventor
Paolo Pallado
Original Assignee
Eurand Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurand Int filed Critical Eurand Int
Publication of MXPA02009056A publication Critical patent/MXPA02009056A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

La presente invencion se refiere a un proceso para la impregnacion de polimeros reticulados con un ingrediente activo. El proceso se basa en el uso de fluidos comprimidos, en particular CO2, con efecto antidisolvente e involucra las etapas de impregnacion del polimero con una solucion del ingrediente activo, adicion de un fluido comprimido hasta la precipitacion del ingrediente activo causada por el efecto antidisolvente del fluido comprimido, remocion del disolvente y el fluido comprimido. El proceso permite obtener formulaciones farmaceuticas de liberacion acelerada que, comparado con las formulaciones ya conocidas, contienen mayores cantidades del ingrediente activo amorfo o nanocristalino.
MXPA02009056A 2000-03-17 2001-03-07 Proceso para la preparacion de formulaciones de liberacion acelerada usando fluidos comprimidos. MXPA02009056A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2000MI000560A IT1318404B1 (it) 2000-03-17 2000-03-17 Processo per la preparazione di formulazioni a rilascio accelerato conimpiego di fluidi compressi.
PCT/EP2001/002538 WO2001068054A1 (en) 2000-03-17 2001-03-07 Process for the preparation of accelerated release formulations using compressed fluids

Publications (1)

Publication Number Publication Date
MXPA02009056A true MXPA02009056A (es) 2004-09-06

Family

ID=11444510

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02009056A MXPA02009056A (es) 2000-03-17 2001-03-07 Proceso para la preparacion de formulaciones de liberacion acelerada usando fluidos comprimidos.

Country Status (13)

Country Link
US (1) US6913779B2 (es)
EP (1) EP1267836B1 (es)
JP (1) JP2003526653A (es)
KR (1) KR20030070815A (es)
CN (1) CN1418090A (es)
AT (1) ATE326950T1 (es)
AU (1) AU4068201A (es)
BR (1) BR0109312A (es)
CA (1) CA2403343C (es)
DE (1) DE60119914D1 (es)
IT (1) IT1318404B1 (es)
MX (1) MXPA02009056A (es)
WO (1) WO2001068054A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE416784T1 (de) * 2000-12-01 2008-12-15 Takeda Pharmaceutical Verfahren zur herstellung einer zubereitung mit einer bioaktiven substanz
GB0126716D0 (en) * 2001-11-07 2002-01-02 Advanced Phytonics Ltd Method for the production of particles
US20050163852A1 (en) * 2002-03-07 2005-07-28 Massimo Bresciani Process for loading and thermodynamically activating drungs on polymers by means of supercritical fluids
GB0205868D0 (en) * 2002-03-13 2002-04-24 Univ Nottingham Polymer composite with internally distributed deposition matter
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
CA2665349A1 (en) * 2006-10-06 2008-04-10 Newsouth Innovations Pty Limited Particle formation
GB0812742D0 (en) * 2008-07-11 2008-08-20 Critical Pharmaceuticals Ltd Process
FR2945449B1 (fr) * 2009-05-15 2012-10-05 Pf Medicament Procede d'impregnation par co2 supercritique
US20110097401A1 (en) 2009-06-12 2011-04-28 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
CN105687141A (zh) * 2016-03-04 2016-06-22 中国药科大学 超临界抗溶剂法制备尼美舒利-左旋聚乳酸(Nim-PLLA)复合微球的工艺研究
CN110859807A (zh) * 2018-08-28 2020-03-06 康芝药业股份有限公司 一种尼美舒利的固体分散微粉及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225192A (en) * 1988-10-17 1993-07-06 Vectorpharma International S.P.A. Poorly soluble medicaments supported on polymer substances in a form suitable for increasing their dissolving rate
IE63321B1 (en) * 1986-02-03 1995-04-05 Elan Corp Plc Drug delivery system
IT1230566B (it) * 1988-10-17 1991-10-28 Vectorpharma Int Farmaci poco solubili supportati su sostanze polimeriche in forma atta all'aumento della velocita' di dissoluzione
CA2017332A1 (en) * 1989-06-29 1990-12-29 Richard W. Greiner Pharmaceutically impregnated catheters
US5340614A (en) * 1993-02-11 1994-08-23 Minnesota Mining And Manufacturing Company Methods of polymer impregnation
ES2170853T3 (es) * 1995-03-28 2002-08-16 Fidia Advanced Biopolymers Srl Nanosferas que comprenden un polisacarido biocompatible.
IT1296464B1 (it) * 1997-11-19 1999-06-25 Vectorpharma Int Composizioni farmaceutiche in forma di polveri di polimeri reticolati caricati con farmaci e relativo processo di preparazione mediante
CA2409003C (en) * 2000-05-16 2010-10-19 Ortho-Mcneil Pharmaceutical, Inc. Process for coating medical devices using super-critical carbon dioxide

Also Published As

Publication number Publication date
EP1267836A1 (en) 2003-01-02
BR0109312A (pt) 2002-12-17
ATE326950T1 (de) 2006-06-15
US20030161957A1 (en) 2003-08-28
CA2403343C (en) 2010-05-11
US6913779B2 (en) 2005-07-05
CN1418090A (zh) 2003-05-14
KR20030070815A (ko) 2003-09-02
CA2403343A1 (en) 2001-09-20
ITMI20000560A1 (it) 2001-09-17
IT1318404B1 (it) 2003-08-25
WO2001068054A1 (en) 2001-09-20
JP2003526653A (ja) 2003-09-09
DE60119914D1 (de) 2006-06-29
EP1267836B1 (en) 2006-05-24
AU4068201A (en) 2001-09-24
ITMI20000560A0 (it) 2000-03-17

Similar Documents

Publication Publication Date Title
MXPA02009056A (es) Proceso para la preparacion de formulaciones de liberacion acelerada usando fluidos comprimidos.
ES1063053Y (es) Dispositivo para producir microespuma
DE60003933D1 (de) Verfahren zur herstellung von mikropartikeln
ATE238813T1 (de) Wirkstoffformulierungen mit verzögerter freisetzung
ATE469179T1 (de) Hydrogel
CA2193129A1 (en) Transdermal drug delivery system
WO2003007879A3 (en) Cartilage repair and regeneration scaffold and method
AU2002321790A1 (en) Device for sampling blood droplets under vacuum conditions
SE0100901D0 (sv) New composition
PT1017367E (pt) Metodos para fabricar preparacoes de libertacao controlada baseadas em polimeros
EP0679390A3 (en) Sprayable topical pharmaceutical compositions
ES2130450T3 (es) Procedimiento para la fabricacion de dispersiones polimeras hidrosolubles con una alta parte polimera.
WO2004100866A3 (en) Alcohol-free transdermal analgesic composition
WO2002038185A3 (en) Injectable sustained release delivery system with loperamide
WO2009095562A3 (fr) Biomateriau permettant la delivrance controlee d'actifs
DE50310435D1 (de) Filmförmige, zerfallsfähige zubereitungen zur wirkstoff-freisetzung und verfahren zu deren herstellung
CA2591307A1 (en) Injectable veterinary composition
DK1171101T3 (da) Fremgangsmåde til fremstilling af en vanduoplöselig amorf depotmatrix
EP1258254A4 (en) COMPOSITIONS FOR DELAYED DELIVERY OF PHYSIOLOGICALLY ACTIVE COMPOUNDS THAT ARE LOW WATER-SOLUBLE, METHOD FOR THE PRODUCTION AND USE THEREOF
ATE326949T1 (de) Verfahren zur herstellung fester dispersionen
BR0012735A (pt) Preparação solida, e, processo para produzir preparações
ATE258045T1 (de) Verfahren zu herstellung von pulverförmigen solubilisationshilfsstoffen für feste pharmazeutische darreichungsformen
MY130445A (en) Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone
WO1999047105A3 (en) Liquid antimicrobial, skin moisturizing formulation
CA2250117A1 (en) Method and composition for cleansing wounds with minimal cytotoxicity for minimal scarring